Jim Cramer Doesn’t Like This Health Care Stock, Sees No Reason To Buy Rambus
Cramer dislikes Rambus and MiniMed, calls GigaCloud highly speculative, sees Babcock & Wilcox as a small bet, and favors ADM and Deere.
Stocks · News reference
GigaCloud Tech (NASDAQ:GCT) sees Q3 sales of $375.000 million-$400.000 million vs $371.765 million analyst estimate.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Cramer dislikes Rambus and MiniMed, calls GigaCloud highly speculative, sees Babcock & Wilcox as a small bet, and favors ADM and Deere.
On Thursday, GigaCloud Tech (NASDAQ:GCT) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial
GigaCloud Technology Inc. (GCT) declined 1.15% to close at $52.51, underperforming the S&P 500's 0.76% loss. Despite beating sector performance over the past month with a 1.72% gain, the stock carries a Zacks Rank #3 (Hold) rating. Analysts expect upcoming earnings of $1.1 per share with 11.11% year-over-year growth, and full-year EPS of $4.18 with 16.43% growth. The stock trades at a Forward P/E of 12.71, below the industry average of 17.88.
While major market indices declined on September 14, 2026, GigaCloud Technology Inc. (GCT) gained 1.68% to $52.74, outperforming the S&P 500's 0.48% loss. The company is expected to report strong earnings growth of 11.11% year-over-year with full-year EPS estimates of $4.18 and revenue of $1.53 billion, though it currently holds a Zacks Rank #3 (Hold) rating with a favorable Forward P/E valuation of 12.41.